L3Harris Technologies
LHX
$288.69
-0.72%
L3Harris Technologies is a leading aerospace and defense contractor that provides advanced communication systems, sensors, avionics, space-based systems, missiles, and unmanned aerial vehicles to military and government customers. As a top-tier defense prime, it distinguishes itself through a broad portfolio spanning software-defined radios, solid rocket motors, and military aircraft modernization. The current investor narrative centers on geopolitical tailwinds from rising defense budgets and the Pentagon's SHIELD program, which have driven recent stock volatility. However, concerns about margin compression and integration costs from prior acquisitions, including Aerojet Rocketdyne, remain key debates.…
LHX
L3Harris Technologies
$288.69
Related headlines
Investment Opinion: Should I buy LHX Today?
Rating: Hold. The thesis is that L3Harris benefits from strong defense tailwinds and a reasonable forward valuation, but near-term technical weakness and margin pressures warrant caution. The analyst consensus is bullish with an average EPS estimate of $19.67, implying a forward P/E of 14.8x at the current price, which suggests significant upside if estimates are met. Supporting evidence: (1) Forward P/E of 21.3x is in line with the industry average of 22x. (2) Revenue grew 2.3% YoY in Q4 2025 to $5.648 billion, with stable government demand. (3) Free cash flow of $2.682 billion provides financial flexibility. (4) The average EPS estimate of $19.67 implies a 14.8x forward P/E, well below the trailing 35.5x. Risks & Conditions: The biggest risks are margin compression (net margin down to 5.3%) and technical weakness (stock down 17.8% in 3 months). This Hold would upgrade to Buy if operating margins stabilize above 10% and the stock breaks above its 200-day moving average. It would downgrade to Sell if revenue growth decelerates below 2% or net margins fall below 4%. Valuation verdict: The stock is fairly valued on a forward basis but overvalued on trailing earnings, making it a wait-and-see opportunity.
Sign up to view all
LHX 12-Month Price Forecast
L3Harris is a classic value trap risk: cheap on forward earnings but expensive on trailing, with deteriorating margins and negative momentum. The base case of modest growth and stable margins is most likely, but the bull case requires a catalyst to re-rate the stock. The bear case is real if margins continue to compress. I would upgrade to bullish if the stock shows a sustained break above its 200-day moving average and operating margins improve. I would downgrade to bearish if net margins fall below 4% or revenue growth turns negative.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on L3Harris Technologies's 12-month outlook, with a consensus price target around $375.30 and implied upside of +30.0% versus the current price.
Average Target
$375.30
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$231 - $375
Analyst target range
With 7 analysts covering the stock, the consensus leans bullish. The average EPS estimate for the next fiscal year is $19.67, with a low of $19.28 and a high of $20.09. Average revenue is estimated at $31.564 billion. While explicit price targets are not provided, the EPS estimates imply a forward P/E of 14.8x based on the current price of $290.77, suggesting significant upside if the company meets expectations. The consensus recommendation is likely a Buy, given recent upgrades from Morgan Stanley (Overweight) and maintained Buy ratings from Citigroup and JP Morgan. The implied upside from current levels to the average target (if calculated from EPS and a reasonable multiple) would be substantial, but without explicit targets, we note the bullish sentiment. The range of EPS estimates is relatively narrow (low to high spread of 4.2%), indicating strong conviction among analysts. The high estimate of $20.09 assumes margin expansion and robust defense spending, while the low estimate of $19.28 may factor in execution risks or budget delays. Recent ratings actions show no downgrades, with Morgan Stanley upgrading from Equal Weight to Overweight in December 2025, reinforcing positive sentiment.
Drowning in data?
Find the real signal!
Bulls vs Bears: LHX Investment Factors
L3Harris presents a mixed picture: strong geopolitical tailwinds and a forward valuation in line with peers support the bull case, while technical weakness and margin compression fuel bearish concerns. The bull case currently has stronger evidence given the structural defense spending increases and analyst optimism, but the stock's recent price action and premium trailing multiples warrant caution. The single most important tension is whether the expected earnings rebound (implied by the forward P/E) will materialize—if margins recover and revenue accelerates, the stock could see significant upside; if not, the premium valuation could compress further.
Bullish
- Geopolitical Tailwinds Boost Defense Spending: Recent U.S. retaliatory strikes against Iran and the Pentagon's SHIELD program have supercharged defense budgets, directly benefiting L3Harris as a top-tier prime contractor. This structural increase in demand provides a sustained revenue tailwind, with analysts estimating average revenue of $31.56 billion for the next fiscal year.
- Forward P/E in Line with Peers: The forward P/E of 21.3x aligns with the Aerospace & Defense industry average of ~22x, suggesting the stock is fairly valued on expected earnings. This multiple implies the market anticipates a significant earnings rebound from the depressed trailing EPS of $1.60.
- Strong Free Cash Flow Generation: Trailing twelve-month free cash flow stands at $2.682 billion, providing ample coverage for dividends and capital expenditures. This cash generation supports internal funding of growth initiatives and reduces reliance on debt financing.
- Analyst Consensus Bullish with Narrow Estimates: The average EPS estimate for the next fiscal year is $19.67, with a narrow range of $19.28 to $20.09, indicating strong analyst conviction. Recent upgrades include Morgan Stanley's move from Equal Weight to Overweight in December 2025.
Bearish
- Sharp Downtrend and Technical Weakness: The stock has declined 17.8% over the past three months and 4.0% in the last month, significantly underperforming the S&P 500 by 28.9% and 8.1%, respectively. It trades near the low end of its 52-week range at $290.77, below its 200-day moving average, confirming bearish momentum.
- Margin Compression Despite Revenue Growth: Operating margin contracted to 7.0% in Q4 2025 from 11.0% a year earlier, driven by higher SG&A and R&D costs. Net margin fell to 5.3% from 8.2%, indicating profitability pressure that could persist if cost controls are not improved.
- Trailing P/E Premium to Industry: The trailing P/E of 35.5x is 61% above the industry average of 22x, suggesting the stock is expensive based on current earnings. This premium may not be justified if the expected earnings rebound fails to materialize.
- Disruption from New Entrants: Private companies like Saronic are developing robotic warships and autonomous vessels, potentially disrupting traditional defense contractors. The Navy's pivot to faster, cheaper solutions from non-traditional vendors could erode L3Harris's market share in unmanned systems.
LHX Technical Analysis
The stock is in a clear downtrend, with a 1-year price change of +11.8% masking a sharp reversal from its 52-week high of $379.23. Currently trading at $290.77, the stock sits at 76.6% of its 52-week range, near the low end, suggesting bearish momentum and potential value trap dynamics. The price has broken below its 200-day moving average, confirming the negative trend. Short-term momentum is decisively negative, with a 1-month change of -4.0% and a 3-month change of -17.8%, both underperforming the S&P 500 by over 8% and 28%, respectively. This divergence from the positive 1-year return indicates a significant loss of near-term momentum, potentially signaling a trend reversal or a temporary pullback ahead of earnings. The 52-week low of $257.35 provides key support, while resistance sits at the 52-week high of $379.23. A breakdown below $257.35 would signal further downside, while a move above $379.23 would indicate a resumption of the uptrend. With a beta of 0.75, the stock is less volatile than the market, which may offer some downside protection but also limits upside participation in broad rallies.
Beta
0.75
0.75x market volatility
Max Drawdown
-24.5%
Largest decline past year
52-Week Range
$257-$379
Price range past year
Annual Return
+11.2%
Cumulative gain past year
| Period | LHX Return | S&P 500 |
|---|---|---|
| 1m | -6.2% | +1.0% |
| 3m | -18.8% | +7.9% |
| 6m | -15.8% | +8.5% |
| 1y | +11.2% | +20.1% |
| ytd | -5.2% | +9.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LHX Fundamental Analysis
Revenue growth remains modest but steady, with the most recent quarter (Q4 2025) reporting $5.648 billion, up 2.3% year-over-year. Over the trailing four quarters, revenue has grown from $5.232 billion (Q1 2025) to $5.648 billion, indicating a decelerating but positive trajectory. Segment data shows Space and Airborne Systems ($6.946B) and Integrated Mission Systems ($6.630B) as the largest contributors, while Aerojet Rocketdyne ($2.845B) adds diversification. The growth rate, while below some defense peers, reflects stable government demand. Profitability is solid but under pressure: net income for Q4 2025 was $300 million, with a net margin of 5.3%, down from 8.2% in the year-ago quarter. Gross margin improved to 25.6% from 21.8% a year earlier, but operating margin compressed to 7.0% from 11.0%, driven by higher SG&A and R&D costs. The company remains profitable with a trailing EPS of $1.60, but margin trends warrant monitoring. The balance sheet is healthy: debt-to-equity stands at 0.57, and the current ratio is 1.19, indicating adequate liquidity. Free cash flow for the trailing twelve months is $2.682 billion, providing ample coverage for dividends and capex. ROE is 8.2%, reflecting moderate returns on equity. The company generated $1.962 billion in operating cash flow in Q4 2025, supporting internal funding of growth initiatives.
Quarterly Revenue
$5.6B
2026-01
Revenue YoY Growth
+2.3%
YoY Comparison
Gross Margin
25.6%
Latest Quarter
Free Cash Flow
$2.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LHX Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 35.5x, while the forward P/E is 21.3x, implying the market expects significant earnings growth in the coming year. The gap between trailing and forward multiples suggests optimism about margin recovery or revenue acceleration. Compared to the Aerospace & Defense industry average P/E of approximately 22x, L3Harris trades at a 61% premium on a trailing basis, but the forward P/E of 21.3x is in line with the sector. This premium may be justified by the company's diversified portfolio and exposure to high-growth areas like space and unmanned systems. Historically, the stock's trailing P/E has ranged from 21.5x (Q4 2021) to 63.2x (Q4 2023), with the current 35.5x near the middle of that range. This suggests the stock is not excessively overvalued relative to its own history, but the forward multiple implies that current earnings are depressed and expected to rebound.
PE
35.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -33x~63x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: L3Harris's net margin declined from 8.2% to 5.3% year-over-year in Q4 2025, while operating margin fell from 11.0% to 7.0%, indicating cost pressures from higher SG&A and R&D spending. The trailing P/E of 35.5x is elevated relative to the industry average of 22x, making the stock vulnerable to multiple compression if earnings disappoint. Debt-to-equity is manageable at 0.57, but interest expense of $143 million in Q4 2025 consumes a portion of operating income. Market & Competitive Risks: The stock's beta of 0.75 suggests lower volatility than the market, but its recent underperformance (3-month -17.8% vs. S&P 500 +11.1%) indicates company-specific headwinds. Competitive disruption from private firms like Saronic in autonomous vessels and the Pentagon's SHIELD program's shift to a competitive marketplace could pressure margins and market share. Regulatory risks include potential budget delays or changes in defense spending priorities. Worst-Case Scenario: A combination of continued margin compression, a slowdown in defense spending growth, and a broad market downturn could drive the stock to its 52-week low of $257.35, representing a 11.5% decline from the current price of $290.77. In a severe recession or geopolitical de-escalation, the stock could test historical support levels, with a potential drawdown of 24.5% (max drawdown) to $219.50.
FAQ
The key risks are: (1) Margin compression—net margin fell to 5.3% in Q4 2025 from 8.2% a year ago, and operating margin dropped to 7.0% from 11.0%. (2) Valuation risk—the trailing P/E of 35.5x is well above the industry average of 22x, making the stock vulnerable to multiple compression. (3) Competitive disruption—private companies like Saronic are developing autonomous vessels that could erode market share. (4) Technical risk—the stock is in a downtrend, down 17.8% in three months and trading below its 200-day moving average. The most severe risk is a continued earnings miss that could drive the stock to its 52-week low of $257.35, a 11.5% decline from current levels.
The 12-month forecast is mixed: the bull case (30% probability) sees the stock reaching $340-$380, driven by geopolitical escalation and margin expansion. The base case (45% probability) targets $290-$340, assuming modest growth and stable margins. The bear case (25% probability) sees the stock falling to $257-$290 if margins continue to compress. The most likely scenario is the base case, with the stock trading near current levels. Key assumptions include revenue growth of 2-3% and operating margins stabilizing around 8-9%. The average analyst EPS estimate of $19.67 implies a forward P/E of 14.8x at the current price, suggesting upside if estimates are met.
L3Harris is fairly valued on a forward basis but overvalued on trailing earnings. The forward P/E of 21.3x is in line with the Aerospace & Defense industry average of 22x, suggesting the market expects earnings to rebound. However, the trailing P/E of 35.5x is 61% above the industry average, indicating that current earnings are depressed. The PEG ratio of 4.26x implies the stock is expensive relative to its growth rate. Historically, the trailing P/E has ranged from 21.5x to 63.2x, so the current 35.5x is near the middle. The market is pricing in a recovery, but if that recovery fails, the stock could be overvalued.
L3Harris is a hold rather than a buy at current levels. The stock offers a forward P/E of 21.3x, in line with the industry average, and analysts expect EPS of $19.67 next year, implying significant upside if achieved. However, the trailing P/E of 35.5x and recent margin compression (net margin down to 5.3% from 8.2%) suggest near-term risks. The biggest downside is a continued earnings miss that could compress the multiple further. For long-term investors with a 12-month horizon, it could be a good buy if margins stabilize and the stock breaks above its 200-day moving average. For short-term traders, the negative momentum makes it risky.
L3Harris is more suitable for long-term investment (12+ months) given its exposure to structural defense spending and reasonable forward valuation. The stock's beta of 0.75 indicates lower volatility than the market, which may appeal to conservative investors. However, the recent downtrend and margin pressures make it less attractive for short-term trading. The dividend yield of 1.58% provides some income, but the payout ratio of 56% is moderate. For long-term investors, a minimum holding period of 12 months is recommended to allow for margin recovery and earnings growth. Short-term traders should wait for a technical breakout above the 200-day moving average before entering.
